日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Generation of a safe and efficacious llama single-domain antibody fragment (vHH) targeting the membrane-proximal region of 4-1BB for engineering therapeutic bispecific antibodies for cancer

生成安全有效的骆驼单域抗体片段 (vHH),靶向 4-1BB 的膜近端区域,用于设计治疗癌症的双特异性抗体

Tianhang Zhai, Chao Wang, Yifeng Xu, Weifeng Huang, Zhijun Yuan, Tao Wang, Shuang Dai, Shaogang Peng, Tuling Pang, Wenchao Jiang, Yuhua Huang, Yuefeng Zou, Yingda Xu, Joanne Sun, Xinjiang Gong, Jinping Zhang, Andy Tsun, Bin Li, Xiaoniu Miao

A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy

一种新型双位点杂交抗体-ACE2融合物可阻断SARS-CoV-2感染:对治疗的意义

Xiaoniu Miao ,Yi Luo ,Xi Huang ,Suki M Y Lee ,Zhijun Yuan ,Yongzhou Tang ,Liandi Chen ,Chao Wang ,Fan Wu ,Yifeng Xu ,Wenchao Jiang ,Wei Gao ,Xuedong Song ,Yao Yan ,Tuling Pang ,Cheng Chen ,Yuefeng Zou ,Weihui Fu ,Liping Wan ,Javier Gilbert-Jaramillo ,Michael Knight ,Tiong Kit Tan ,Pramila Rijal ,Alain Townsend ,Joanne Sun ,Xiaolin Liu ,William James ,Andy Tsun ,Yingda Xu